Insight

David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

David J. Benjamin/X

Sep 5, 2024, 07:11

David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

David J. Benjamin, Hematology-Oncology specialist, shared a post on X:

“Congratulations Andrea Apolo and colleagues on the latest publication in Patient Journal. With a growing armamentarium of therapies, it is critical for oncologists to understand what is important to individuals being treated for locally advanced/metastatic urothelial carcinoma.”

Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding

Authors: Andrea B. Apolo, Christine Michaels-Igbokwe, Nicholas I. Simon, David J. Benjamin, Mallory Farrar, Zsolt Hepp, Lisa Mucha, Sebastian Heidenreich, Katelyn Cutts, Nicolas Krucien, Natasha Ramachandran & John L. Gore

Source: David J. Benjamin/X

Andrea Apolo Andrea B Apolo cancer cancer awareness Christine Michaels-Igbokwe David J. Benjamin John L. Gore Katelyn Cutts Lisa Mucha Mallory Farrar Natasha Ramachandran Nicholas I Simon Nicolas Krucien OncoDaily Oncology Patient Journal Sebastian Heidenreich Zsolt Hepp

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage